CMU’s med school obtains key accreditation

Central Michigan University’s College of Medicine has achieved a new level of accreditation that now ranks its continuing medical education programs for faculty equivalent to the top medical schools in the United States.

After a thorough review of CMU’s Office of Continuing Medical Education, the national Accreditation Council for Continuing Medical Education decided to award the college accreditation with commendation through 2024 as a provider of continuing medical education for physicians.

Doctors study ‘compassion crisis’

CAMDEN, N.J. — Stephen Trzeciak’s obsession with compassion started with his son’s seventh-grade cultural geography assignment three years ago.

The son asked the father, a critical-care doctor at Cooper University Hospital, for help with a speech that would count for half his grade. Trzeciak saw a father-son bonding opportunity. Then he read the formidable question his 12-year-old was expected to answer: What is the most pressing problem of our time?

UC San Diego medical school reaches for the top as it turns 50

Fifty years after it enrolled its first medical students, UC San Diego is crackling with optimism, having created one of the country’s most respected medical schools in a comparatively short period of time.

US News and World Report says the medical school is among the 20 best in the country in research and primary care — rankings partly based on the university’s history of developing drugs and treating cancer patients.

The magazine also points to UC San Diego’s exclusivity. The medical school accepts 3 percent of its applicants, making it nearly as hard to get into as the far older programs at Stanford and Georgetown.

Effectiveness of peer teaching in medical education: medical student’s perspective

As three clinical-year medical students in the United Kingdom, we were particularly intrigued by Elhassan’s1 research into a weekly educational activity called the “hospitalist huddle” in the United States. It explored the concept of peer teaching among doctors and its effectiveness. In this letter, we will discuss the usefulness of peer teaching for medical students as well as the different educational opportunities similar to the “hospitalist huddle” that exist in UK hospitals.

Author's reply

Mohammed Elhassan

Department of Internal Medicine, Division of Hospital Medicine, UCSF/Fresno Center for Medical Education and Research, Fresno, CA, USA

I read with interest and joy the letter written by Omar, Zaheer, and Ahmed, all clinical-year medical students in the United Kingdom, regarding their experience with peer and near-peer teaching in their institution. It is a delight to learn that their experience with this medical education tool is positive and affirmative. This adds support to the notion that teaching with flat hierarchy is truly appealing for medial learners at different educational levels and within different clinical settings, not only in the US, but also in other similar medical education systems.

View the original paper by Elhassan


Source >>

Precision medicine: Access to real-time genetic testing data impacts prescriber behavior following minimally invasive stent procedure

For the first time, Penn study finds clinicians are influenced by patients' genetic makeup when prescribing antiplatelet drug regimens

UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE


PHILADELPHIA - Today, in a late-breaking featured clinical research session at the American College of Cardiology Scientific Sessions 2018, researchers from Penn Medicine present first-of-its-kind data on the impact of real-time CYP2C19 genotype results when prescribing antiplatelet drugs in the clinic.

Following percutaneous coronary intervention (PCI)--a minimally invasive procedure for the treatment of narrowing arteries inside the heart--patients are often prescribed aspirin and antiplatelet medications, which keep stents open by preventing blood platelets from sticking together. However, existing research suggests that some patients--specifically those who carry a mutation of the CYP2C19 gene, which impact the liver's ability to process the antiplatelet drug, clopidogrel--may not benefit from this drug, but instead would require different antiplatelet medications, such as prasugrel or ticagrelor, to prevent heart attack and stroke.